Anti-CD19 [CAT-13.1E10]

Absolute Antibody

Anti-CD19 [CAT-13.1E10]

7

CAT 13.1E10 antibody recognises CD19, which is a transmembrane glycoprotein that regulates B lymphocyte development, activation, and differentiation.

This antibody is recommended for targeting and analysis of B cells. CAT-13.1E10 was used as a part of a fusion molecule aimed at intracellular delivery of BINDI in order to establish a potential treatment method of EBV-positive B lymphoma in a xenograft mouse model (US20160376333A1).

Other Application

therapeutics

Research Use Only

Monoclonal

CAT-13.1E10

CD19

CD19 molecule

B4; B-lymphocyte antigen CD19; B-lymphocyte surface antigen B4; CVID3; differentiation antigen CD19; T-cell surface antigen Leu-12

Human

IgG4

B-lymphocyte antigen CD19

This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Human

Human

This antibody was raised by immunising mice against CD19.

-20°C,2°C to 8°C

12352203